These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3248953)

  • 1. Once-daily dosing of sustained-release diltiazem capsules in mild-to-moderate hypertension.
    Ginsberg D; Pappas JE; Rofman BA; Gutgsell TL; Schumer B; Karp R; Walker SD
    J Am Osteopath Assoc; 1988 Dec; 88(12):1489-92. PubMed ID: 3248953
    [No Abstract]   [Full Text] [Related]  

  • 2. A multicentre study to compare the therapeutic efficacy of sustained-release diltiazem and enalapril in the treatment of patients with mild to moderate hypertension.
    Weir RJ; Lee PS; Clegg DS; Hemingray S; Belgrave GP; Walter E
    Br J Clin Pract; 1994; 48(6):287-92. PubMed ID: 7848788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
    Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive efficacy and tolerability of once-daily sustained-release diltiazem alone and in combination with ramipril in hypertension.
    Tuteja R; Swarup D; Saxena GN; Bhandari S; Sharma P
    J Assoc Physicians India; 1999 Oct; 47(10):962-5. PubMed ID: 10778687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diltiazem 180 mg in delayed release formulation in mild and moderate arterial hypertension].
    Serra-Pinto L; Baptista A; Rocha E
    Rev Port Cardiol; 1995 Apr; 14(4):303-10, 283-4. PubMed ID: 7612279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy and safety of sustained-release diltiazem in the treatment of hypertension.
    Myburgh DP
    S Afr Med J; 1990 Oct; 78(8):456-7. PubMed ID: 2218780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once daily perindopril versus slow release diltiazem in the treatment of mild to moderate essential hypertension. Canadian Study Group on Perindopril.
    Can J Cardiol; 1994 Nov; 10 Suppl D():8D-12D. PubMed ID: 7954041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of force titrated doses of diltiazem extended-release. A placebo controlled study.
    Lacourcière Y; Poirier L; Lefebvre J; Burford RG
    Am J Hypertens; 1995 Mar; 8(3):282-6. PubMed ID: 7794578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effectiveness of enalapril plus extended-release diltiazem in essential hypertension.
    Applegate W; Cohen JD; Wolfson P; Davis A; Green S
    Pharmacotherapy; 1997; 17(1):107-12. PubMed ID: 9017770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new extended-release formulation of diltiazem HCl for the treatment of mild-to-moderate hypertension.
    Frishman WH
    J Clin Pharmacol; 1993 Jul; 33(7):612-22. PubMed ID: 8366186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of equal-weight oral dosages of verapamil hydrochloride and diltiazem hydrochloride in patients with mild to moderate hypertension.
    Hollifield JW; Heusner JJ; DesChamps M; Gray J; Spyker DA; Peace KE; Dickson B
    Clin Pharm; 1988 Feb; 7(2):129-34. PubMed ID: 3280220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypotensive effect and characteristics of the effect on the central hemodynamics of the delayed-action form of diltiazem (Dilren) in patients with hypertension].
    Pshenitsin AI; Glotov MN; Mazur NA
    Ter Arkh; 1993; 65(9):47-50. PubMed ID: 8303596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring.
    Leenen FH; Wilson TW; Bolli P; Larochelle P; Myers M; Handa SP; Boileau G; Tanner J
    Can J Cardiol; 1997 Oct; 13(10):914-20. PubMed ID: 9374947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter studies on the pharmacokinetic profile of sustained-release oral diltiazem (300 mg) after once a day repeated administration: influence of age.
    Bianchetti G; Billy S; Ascalone V; Saivin S; Houin G; Rosenzweig P
    Int J Clin Pharmacol Ther; 1996 May; 34(5):195-201. PubMed ID: 8738855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of a once-daily graded-release diltiazem formulation dosed at bedtime compared to placebo and to morning dosing in chronic stable angina pectoris.
    Glasser SP; Gana TJ; Pascual LG; Albert KS
    Am Heart J; 2005 Feb; 149(2):e1-9. PubMed ID: 15846251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled trial of sustained-release diltiazem in patients with angina. Sustained-Release Diltiazem Study Group.
    Weiss RJ; Hicks D; Bittar N; Bowers J; Shah A
    Clin Ther; 1993; 15(6):1069-75. PubMed ID: 8111804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diltiazem for treatment of essential hypertension: a double-blind controlled study with reserpine.
    Ogawa K; Ban M; Ito T; Watanabe T; Kobayashi T; Yamazaki N; Suzuki Y
    Clin Ther; 1984; 6(6):844-53. PubMed ID: 6391669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy and tolerability of an angiotensin converting enzyme inhibitor (lisinopril) versus a calcium channel antagonist (diltiazem SR) in the treatment of moderate to severe hypertension.
    Weir MR; Fagan T; Chrysant S; Flamenbaum W; Kaihlanen PM; Lueg M; Anzalone D
    J Hum Hypertens; 1994 Jul; 8(7):531-7. PubMed ID: 7932518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
    Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pharmaceutical formulation for diltiazem on health care expenditures for hypertension.
    Skaer TL; Sclar DA; Robison LM; Markowski DJ; Won JK
    Clin Ther; 1993; 15(5):905-11. PubMed ID: 8269458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.